Viking Global Investors’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $801M | Sell |
18,555,375
-3,500,000
| -16% | -$151M | 2.32% | 10 |
|
|
2025
Q1 | $762M | Sell |
22,055,375
-3,065,616
| -12% | -$106M | 2.42% | 12 |
|
|
2024
Q4 | $689M | Hold |
25,120,991
| – | – | 2.23% | 17 |
|
|
2024
Q3 | $640M | Hold |
25,120,991
| – | – | 2.33% | 16 |
|
|
2024
Q2 | $636M | Hold |
25,120,991
| – | – | 2.45% | 14 |
|
|
2024
Q1 | $777M | Hold |
25,120,991
| – | – | 2.89% | 9 |
|
|
2023
Q4 | $1.01B | Hold |
25,120,991
| – | – | 3.71% | 7 |
|
|
2023
Q3 | $662M | Sell |
25,120,991
-1,500,000
| -6% | -$39.6M | 2.69% | 12 |
|
|
2023
Q2 | $458M | Hold |
26,620,991
| – | – | 1.87% | 17 |
|
|
2023
Q1 | $441M | Hold |
26,620,991
| – | – | 2.07% | 18 |
|
|
2022
Q4 | $203M | Hold |
26,620,991
| – | – | 1.02% | 31 |
|
|
2022
Q3 | $265M | Hold |
26,620,991
| – | – | 1.22% | 31 |
|
|
2022
Q2 | $242M | Hold |
26,620,991
| – | – | 1.11% | 33 |
|
|
2022
Q1 | $270M | Hold |
26,620,991
| – | – | 1.09% | 31 |
|
|
2021
Q4 | $444M | Hold |
26,620,991
| – | – | 1.28% | 24 |
|
|
2021
Q3 | $1.25B | Hold |
26,620,991
| – | – | 3.42% | 4 |
|
|
2021
Q2 | $1.62B | Hold |
26,620,991
| – | – | 4.92% | 2 |
|
|
2021
Q1 | $1.64B | Hold |
26,620,991
| – | – | 4.88% | 2 |
|
|
2020
Q4 | $1.89B | Hold |
26,620,991
| – | – | 5.21% | 2 |
|
|
2020
Q3 | $999M | Hold |
26,620,991
| – | – | 3.61% | 6 |
|
|
2020
Q2 | $868M | Hold |
26,620,991
| – | – | 3.75% | 7 |
|
|
2020
Q1 | $772M | Hold |
26,620,991
| – | – | 4.02% | 7 |
|
|
2019
Q4 | $933M | Hold |
26,620,991
| – | – | 4.37% | 6 |
|
|
2019
Q3 | $572M | Hold |
26,620,991
| – | – | 2.98% | 13 |
|
|
2019
Q2 | $718M | Buy |
+26,620,991
| New | +$718M | 3.22% | 12 |
|